Josh was President and Chief Executive Officer at Dyne Therapeutics, and Chief Operating Officer and Chief Financial Officer at Kaleido Biosciences. Josh Brumm joined Forbion in 2024.
Josh Brumm is currently
Create your alert
to follow the career of Josh Brumm.
Josh Brumm graduated from Purdue University and from University of Notre Dame.
They have also studied at Purdue University :
Find more alumni from Purdue University
They have also studied at University of Notre Dame :
Find more alumni from University of Notre Dame
Do you need to know more about Josh Brumm? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.